Hims & Hers Health's revenue grew 59% to $2.35B in 2025, while adjusted EBITDA surged nearly 80% to $318M. Click here to find out why HIMS is a Strong Buy.
Tesla, Inc. remains a Buy as it aggressively pivots into a vertically integrated physical AI utility. Learn more about TSLA stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results